Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Subcutaan ofatumumab effectief bij RRMS: MIRROR-studie
jul 2018 | Multipele Sclerose